Melanoma
T-VEC is a genetically modified herpes simplex virus-1 that contains a gene for granulocyte-macrophage colony-stimulating factor (GM-CSF). The product is injected directly into the tumor.
T-VEC is a genetically modified herpes simplex virus-1 that contains a gene for granulocyte-macrophage colony-stimulating factor (GM-CSF). The product is injected directly into the tumor.
Immunotherapy T-VEC ( FDA-approved )
T-VEC is a genetically modified herpes simplex virus-1 that contains a gene for granulocyte-macrophage colony-stimulating factor (GM-CSF). The product is injected directly into the tumor, while GM-CSF stimulates T-cell production so they better recognize proteins released by the tumor, effectively attacking and destroying them.
For melanoma treatment, it is injected directly into the skin lesion.
Discusses whether anyone can start training.Book a visit — we will pick a convenient time.